AbbVie News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.16 -0.13% 121.35 12:52:41
Open Price Low Price High Price Close Price Prev Close
121.96 120.75 122.44 121.51
more quote information »

Recent News

Date Time Source Heading
12/08/202111:11IHNWFeaturedCybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate CYB003 for the Treatment of Major Depressive Disorder and Alcohol Use Disorder
12/08/20219:37IHNWFeaturedHealixa Appoints Rep. Denver Riggleman to the Board of Directors
12/08/20218:34IHNWFeaturedMax Resource Identifies 5 Drill Target Zones and Reports New Assay Results from DT-3 at URU, CESAR Project, NE Colombia
12/08/20218:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Receives Walmart Purchase Orders of $277,000+ for In-Store Product Sales
12/08/202112:37SEEKAbbVie division Allergan in $200M settlement with New York..
12/08/202111:34TRMNAbbVie Stock: Strong Dividend Growth and Reasonably Valued
12/07/202104:17TRMNLeerink Partners Believes AbbVie (ABBV) Still Has Room to..
12/06/202109:20DJNAbbVie: Rinvoq Meets Key Endpoints in Phase 3 Crohn's..
12/06/202109:06SEEKAbbvie’s Rinvoq achieves primary endpoint in late-stage..
12/06/202108:30PRNUSUpadacitinib (RINVOQ®) Achieved Primary and Key Secondary..
12/06/202107:25TRMNAbbVie Updates RINVOQ Indications for the Treatment of RA in..
12/03/202116:43SEEKAbbVie updates U.S. labeling info for RINVOQ in rheumatoid..
12/03/202116:15PRNUSAbbVie Provides Update on RINVOQ® (upadacitinib) for the..
11/30/202117:00QUIVRNew Corporate Lobbying data: $ABBV recently disclosed $300..
11/30/202108:58DJNAbbVie Submits Europe Application for Risankizumab for..
11/30/202108:11SEEKAbbVie submits risankizumab application to EMA in Crohn's..
11/30/202108:05PRNUSAbbVie Submits Application for Risankizumab (SKYRIZI®) in..
11/24/202111:53TRMNBerenberg Bank Reaffirms Their Hold Rating on AbbVie (ABBV)
11/23/202110:33SEEKAbbVie upgraded to buy at Societe Generale; sees 48% upside
11/23/202108:15PRNUSAbbVie to Present at the Evercore ISI Conference
11/23/202108:00PRNUSAbbVie to Present at the Piper Sandler Healthcare Conference
11/19/202108:00PRNUSAllergan Aesthetics To Present Data From Its Leading..
11/18/202109:00PRNUSNew Literature Review Highlights Economic Benefits..
11/18/202107:01PRNCAAbbVie annonce le premier remboursement provincial, au..
11/18/202104:36TRMNAbbVie’s Gets EC Approval for SKYRIZI
11/17/202102:50SEEKEuropean Commission approves AbbVie's Skyrizi for psoriatic..
11/17/202102:05PRNUSAbbVie Expands Immunology Portfolio in the European Union..
11/15/202108:30PRNUSAllergan Aesthetics Celebrates Third Annual BOTOX® Cosmetic..
11/10/202108:30PRNUSAbbVie, University of Chicago Extend Research Collaboration..
11/10/202108:00PRNUSAbbVie to Present at the Wolfe Research Healthcare..
11/09/202109:39SEEKNew AbbVie data on Rinvoq shows efficacy in psoriatic..
11/09/202108:45PRNUSAbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ®)..
11/09/202108:31PRNUSAbbVie to Present New Long-term Analysis Evaluating the..
11/08/202108:30PRNUSAllergan, an AbbVie Company, to Present New Data from its..
11/08/202106:43TRMNAbbVie Presents Data from Two Phase 3 Trials on Risankizumab
11/06/202116:00SEEKA look at Abbvie based on SA Quant analysis: How does it..
11/05/202111:03SEEKNew AbbVie Skyrizi data shows improvements in psoriatic..
11/05/202110:06PRNUSAbbVie Presents Integrated Efficacy and Safety Data From Two..
11/04/202117:35EDGARStatement of Changes in Beneficial Ownership (4)
11/04/202109:05PRNUSAbbVie to Highlight New Advances in Blood Cancer Research..
11/01/202108:31PRNUSAbbVie Highlights Innovative Research From Its Rheumatology..
11/01/202102:56TRMNAbbVie’s 2021 Earnings Outlook Exceeds Estimates; Shares Up..
10/29/202117:31PRNUSU.S. Food and Drug Administration Approves VUITY™..
10/29/202113:53SEEKFDA approves Abbvie's Vuity eye drops for age-related..
10/29/202111:54DJNAbbVie Shares Up After Earnings Beat and Guidance Boost
10/29/202109:08TRMNAbbVie’s ABBV-951 Phase 3 Study Reflects Optimism; Shares..
10/29/202108:54DJNAbbVie to Seek FDA Nod for Vraylar as Adjunct Treatment for..
10/29/202108:41DJNAbbVie Boosts Quarterly Dividend by 8.5%
10/29/202108:29DJNAbbVie Boosts 2021 Earnings Forecast
10/29/202108:17SEEKAbbVie sets better-than-expected 2021 guidance despite..
10/29/202108:03SEEKAbbVie's cariprazine meets main goal in late-stage major..
10/29/202107:50PRNUSAbbVie's Cariprazine (VRAYLAR®) Met Primary Endpoint in..
10/29/202107:47SEEKAbbVie hikes dividend by ~9% to $1.41 per share, stock..
10/29/202107:43SEEKAbbVie EPS beats by $0.11, beats on revenue, raises guidance
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.